Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

IL-23: Long-term Data and Safety Data
November 19, 2019 – 
A review of the IL-23 inhibitors and their long-term and safety data.
Decreased Efficacy, PASI Score vs BSA, and Nonresponders
November 19, 2019 – 
The panel discusses the potential for decreased efficacy of treatment based on comorbidities. They also discuss the use of PASI score vs BSA to determine severity of disease and the need to identify responders and nonresponders to specific agents.
Comorbidities and Changes in Treatment Plan
November 12, 2019 – 
Experts delve into their treatment plan based on additional comorbidities patients may have.
Treating Insomnia With Dual Orexin Receptor Antagonists
November 12, 2019 – 
A discussion on the dual orexin receptor antagonist suvorexant, and its role in treating elderly patients with insomnia.
The Role of "Z-Drugs" in Treating Insomnia
November 12, 2019 – 
Experts in the field of insomnia consider the efficacy of “Z-drugs” in treating insomnia, and the adverse effects of prescription medications.
Patient Preferences and Payer Approval of Treatment
November 12, 2019 – 
A discussion on the patient preference for specific medications based on administration and dosing schedule, and the payer approval process.
Future Directions of Sickle Cell Disease Management
November 06, 2019 – 
Concluding their reflection on gene therapy, the panelists provide closing considerations for the future management of sickle cell disease.
Identifying the Differing Mechanisms of Available Biologics
November 05, 2019 – 
The panel provides an understanding of the different biologics and the various mechanisms of action.
Prescription Options for the Elderly With Insomnia
November 05, 2019 – 
Key opinion leaders enumerate the prescription medication options available for elderly patients with insomnia.
When to Treat Insomnia With Prescription Medication
November 05, 2019 – 
When to transition from over-the-counter treatment options to prescription medication.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.